Abecma (idecabtagene vicleucel)

pCPA File Number: 21655
Negotiation Status:
Negotiations were not pursued
For the treatment of adult patients with multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody and who are refractory to their last treatment
Celgene Inc.
CADTH Project Number:
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: